Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-101865
Filing Date
2016-05-13
Accepted
2016-05-13 17:01:23
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v438102_10q.htm 10-Q 426553
2 EXHIBIT 31.1 v438102_ex31-1.htm EX-31.1 10951
3 EXHIBIT 31.2 v438102_ex31-2.htm EX-31.2 10766
4 EXHIBIT 32.1 v438102_ex32-1.htm EX-32.1 4801
  Complete submission text file 0001144204-16-101865.txt   3359296

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mtnb-20160331.xml EX-101.INS 653120
6 XBRL TAXONOMY EXTENSION SCHEMA mtnb-20160331.xsd EX-101.SCH 36886
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtnb-20160331_cal.xml EX-101.CAL 37147
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtnb-20160331_def.xml EX-101.DEF 207557
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtnb-20160331_lab.xml EX-101.LAB 259645
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtnb-20160331_pre.xml EX-101.PRE 247521
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-193455 | Film No.: 161649259
SIC: 2834 Pharmaceutical Preparations